GO:0070060 'de novo' actin filament nucleation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070060 describes the nucleation of actin filaments from monomers without a pre-existing filament, producing unbranched filaments.
• Formins are the principal catalysts of de novo nucleation, using their FH2 domains to stabilize actin dimers and promote elongation.
• The process is essential for diverse cellular structures, including stress fibers, filopodia, and the contractile ring.
• De novo nucleation is spatiotemporally regulated and can cooperate with Arp2/3 complex in specific contexts.
• Dysregulation of de novo nucleation is implicated in cancer, developmental defects, and nuclear actin-related genome stability.
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of nucleation factor function.
Description
Actin filaments are fundamental to cell shape, motility, and division. The initial step of filament formation, nucleation, is rate-limiting and must be tightly controlled. GO:0070060, 'de novo' actin filament nucleation, defines the process by which actin monomers assemble into a nucleus in the absence of any existing actin filament, leading to an unbranched filament. This term is distinct from branched nucleation mediated by the Arp2/3 complex, and it is primarily driven by formin family proteins. Understanding de novo nucleation is critical for researchers studying cytoskeletal dynamics, as it underlies the formation of linear actin structures such as stress fibers, filopodia, and the cytokinetic ring. Moreover, recent work has revealed cooperative interactions between formins and Arp2/3 in maintaining cortical actin arrays, and nuclear de novo nucleation has been linked to DNA repair. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0070060, its molecular players, and experimental approaches.
'de novo' actin filament nucleation At A Glance
| GO ID | GO:0070060 |
|---|---|
| GO term | 'de novo' actin filament nucleation |
| Ontology | biological_process |
| Synonym | formin-mediated actin filament nucleation; unbranched actin filament nucleation |
| Definition | The actin nucleation process in which actin monomers combine in the absence of any existing actin filaments; elongation of the actin oligomer formed by nucleation leads to the formation of an unbranched filament. |
| Major function | Generation of unbranched actin filaments for cellular structures such as stress fibers, filopodia, and contractile rings. |
| Key regulators | Formin homology proteins (e.g., DIAPH1, FMNL1), profilin-actin complexes, and Rho GTPases. |
| Cellular contexts | Cytokinesis, cell migration, morphogenesis, and nuclear actin dynamics. |
What Is GO:0070060?
According to the Gene Ontology, 'de novo' actin filament nucleation (GO:0070060) is the actin nucleation process in which actin monomers combine in the absence of any existing actin filaments; elongation of the actin oligomer formed by nucleation leads to the formation of an unbranched filament. This definition distinguishes it from branched nucleation and from elongation or severing processes. The term is synonymous with formin-mediated actin filament nucleation and unbranched actin filament nucleation.
Why Is 'de novo' actin filament nucleation Important in Cell Biology?
De novo actin filament nucleation is a cornerstone of cytoskeletal self-organization. It provides the initial seed for unbranched actin polymers that are essential for mechanical support, force generation, and intracellular transport. Because nucleation is the rate-limiting step, its regulation dictates where and when new filaments form, impacting processes from cell division to wound healing. Defects in nucleation factors are associated with human diseases, including immunodeficiencies, cancer metastasis, and neurodevelopmental disorders. Thus, studying GO:0070060 offers mechanistic insights into both basic cell biology and disease pathogenesis.
• Enables formation of unbranched actin filaments required for filopodia and stress fibers.
• Critical for cytokinesis, as the contractile ring depends on de novo nucleation.
• Regulates cell migration and invasion, with implications for cancer metastasis.
• Cooperates with Arp2/3 complex to maintain cortical actin homeostasis.
• Involved in nuclear actin polymerization for DNA repair and genome stability.
• Targeted by bacterial pathogens to manipulate host cytoskeleton.
• Essential for developmental processes such as dorsal closure and axon guidance.
• Dysregulation linked to cardiovascular and immune disorders.
• Provides a model system for studying protein self-assembly and nucleation kinetics.
• Offers therapeutic targets for diseases involving aberrant actin dynamics.
What Happens During 'de novo' actin filament nucleation?
Actin Monomer Activation and Profilin Binding
In simple terms: Actin monomers are prepared for assembly by binding to profilin.
In the cytoplasm, actin monomers (G-actin) are bound by profilin, which delivers them to formin homology 2 (FH2) domains. Profilin-actin complexes are the primary substrate for de novo nucleation. This interaction ensures that nucleation is coupled to the available pool of ATP-actin and prevents spontaneous, uncontrolled polymerization.
Formin-Mediated Dimer Stabilization
In simple terms: Formin proteins hold two actin monomers together to form a stable seed.
Formins, such as DIAPH1 and FMNL1, use their FH2 domains to bind two actin monomers and stabilize the otherwise transient dimer. This stabilization lowers the kinetic barrier for nucleation. The FH2 domain forms a ring-like structure that remains associated with the barbed end, allowing processive elongation.
Elongation and Filament Maturation
In simple terms: Once the seed is formed, actin monomers add rapidly to create a long filament.
After nucleation, the FH2 domain facilitates the addition of profilin-actin to the barbed end, promoting rapid elongation. The resulting filament is unbranched because formins do not create branches. Elongation continues until regulatory cues, such as capping proteins or depolymerization, terminate the process.
Cooperation with Other Nucleators
In simple terms: Formins can work together with other actin assembly factors.
In some cellular contexts, de novo nucleation by formins cooperates with the Arp2/3 complex to build complex actin networks. For example, in Arabidopsis epidermal cells, formins and Arp2/3 act cooperatively to maintain the cortical array. This interplay allows cells to fine-tune actin architecture in response to developmental or environmental signals.
Spatiotemporal Regulation
In simple terms: The cell controls where and when nucleation happens.
De novo nucleation is tightly regulated by Rho GTPases, which activate formins at specific locations such as the plasma membrane or the cleavage furrow. Phosphorylation and autoinhibition also control formin activity. This spatial control ensures that unbranched filaments are generated only where needed, for example during cytokinesis or cell migration.
Key Genes Involved in GO:0070060 'de novo' actin filament nucleation
The following genes and proteins are central to 'de novo' actin filament nucleation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DIAPH1 | Formin that nucleates unbranched actin filaments | Mutations cause deafness and platelet disorders; target for cancer studies |
| DIAPH2 | Formin involved in cytokinesis and cell polarity | Associated with premature ovarian failure |
| DIAPH3 | Formin regulating filopodia and cell migration | Implicated in cancer progression |
| FMNL1 | Formin mediating lamellipodia and invadopodia | Role in immune cell migration and metastasis |
| FMNL2 | Formin involved in cell adhesion and migration | Linked to colorectal cancer |
| FMNL3 | Formin regulating angiogenesis and cell shape | Potential target in vascular diseases |
| INF2 | Formin that accelerates actin polymerization | Mutations cause focal segmental glomerulosclerosis |
| FHOD1 | Formin involved in stress fiber formation | Role in cardiac and skeletal muscle |
| DAAM1 | Formin mediating Wnt signaling and actin assembly | Developmental defects and cancer |
| PFN1 | Profilin that delivers actin monomers to formins | Mutations linked to ALS |
| PFN2 | Profilin isoform in neurons | Neuronal development and degeneration |
| RHOA | GTPase that activates formins | Central regulator of cytoskeleton; cancer and immune disorders |
| RHOC | GTPase activating formins | Overexpressed in cancers |
| CDC42 | GTPase that activates formins and Arp2/3 | Role in filopodia and cell polarity |
| ACTB | Beta-actin, building block of filaments | Mutations cause Baraitser-Winter syndrome |
| ACTG1 | Gamma-actin, component of cytoskeleton | Mutations cause deafness |
| ARP2/3 complex | Branched actin nucleator that can cooperate with formins | Context-dependent cooperation in cortical arrays |
| MYH9 | Myosin II motor that interacts with actin filaments | Mutations cause May-Hegglin anomaly |
How Is 'de novo' actin filament nucleation Regulated?
De novo actin filament nucleation is regulated at multiple levels. Rho family GTPases (RhoA, Rac1, Cdc42) activate formins by relieving autoinhibition. Phosphorylation by kinases such as CDK1 and ROCK modulates formin activity during mitosis. Profilin availability and the actin monomer pool also influence nucleation rates. In addition, capping proteins and tropomyosins regulate filament elongation and stability. Recent studies show that formins and Arp2/3 can act cooperatively, with their balance determining the overall actin architecture. Nuclear de novo nucleation is controlled by DNA damage signals and importin-mediated transport.
'de novo' actin filament nucleation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DIAPH1 | Deafness, platelet disorders, cancer | Knockout mouse, patient-derived iPSCs |
| PFN1 | Amyotrophic lateral sclerosis | Point-mutation knock-in mice, motor neuron cultures |
| INF2 | Focal segmental glomerulosclerosis | Podocyte-specific knockout, kidney organoids |
| FMNL1 | Cancer metastasis | Xenograft models, CRISPR knockout in cancer cell lines |
| ACTB | Baraitser-Winter syndrome | Knock-in mice, patient fibroblasts |
Cancer and Metastasis
Formin-mediated de novo nucleation drives invadopodia and stress fiber formation, which are critical for cancer cell invasion and metastasis. Overexpression of DIAPH3 and FMNL1 has been observed in various cancers, and their inhibition reduces migratory capacity. Thus, targeting de novo nucleation is a potential therapeutic strategy.
Neurodegeneration and ALS
Mutations in profilin-1 (PFN1) impair its interaction with actin and formins, leading to cytoskeletal defects in motor neurons. This has been linked to amyotrophic lateral sclerosis (ALS). De novo nucleation defects may contribute to axonal transport failure and neurodegeneration.
Kidney Disease
Mutations in INF2, a formin that accelerates actin polymerization, cause focal segmental glomerulosclerosis (FSGS) by disrupting podocyte cytoskeleton. This highlights the importance of de novo nucleation in maintaining kidney filtration barrier.
Genome Instability and DNA Repair
Nuclear de novo actin nucleation, mediated by formins, is required for relocalization of heterochromatic breaks and efficient DNA repair. Defects in this process can lead to genomic instability, a hallmark of cancer and aging.
From 'de novo' actin filament nucleation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DIAPH1 affect cytokinesis? | CRISPR knockout in HeLa cells |
| How does PFN1 mutation alter actin nucleation? | Point-mutation knock-in in motor neurons |
| Can INF2 mutation be rescued by wild-type formin? | Knock-in of tagged INF2 in podocytes |
| What is the role of FMNL1 in invasion? | Overexpression and knockout in cancer cell lines |
| Does nuclear actin nucleation require formins? | Knockout of formins in U2OS cells followed by DNA damage |
| How do formins and Arp2/3 cooperate? | Double knockout of formin and Arp2/3 subunits in Arabidopsis |
How to Study the 'de novo' actin filament nucleation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pyrene-actin assay | Nucleation and elongation kinetics | In vitro formin activity |
| Live-cell TIRF microscopy | Single-filament nucleation events | Cell edge dynamics |
| CRISPR knockout screen | Gene essentiality for nucleation | Identifying novel regulators |
| Proximity ligation assay | Protein-protein interactions | Formin-profilin binding |
| Phospho-proteomics | Post-translational modifications | Formin regulation |
| RNA-seq | Transcriptional changes | Knockout vs wild-type |
| Super-resolution microscopy | Nanoscale filament architecture | Nuclear actin structures |
Live-Cell Imaging of Actin Dynamics
Fluorescently labeled actin (e.g., Lifeact-GFP) and formin reporters allow real-time visualization of de novo nucleation events. This method reveals nucleation sites, kinetics, and filament elongation in live cells.
In Vitro Actin Polymerization Assays
Purified actin, profilin, and formin proteins are combined to measure nucleation and elongation rates using pyrene-actin fluorescence. This biochemical approach provides quantitative kinetic parameters.
CRISPR-Based Genetic Screens
Genome-wide knockout libraries can identify genes required for de novo nucleation. Cells are challenged with cytokinesis or migration assays, and sgRNA enrichment is analyzed by sequencing.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry identifies formin-interacting proteins and post-translational modifications. This helps map the nucleation regulatory network.
How CRISPR Can Be Used to Study GO:0070060 'de novo' actin filament nucleation
Knockout
CRISPR knockout of formin genes (e.g., DIAPH1, FMNL1) in cell lines abolishes de novo nucleation, leading to defects in cytokinesis, migration, and stress fiber formation. These models are essential for loss-of-function studies.
Point Mutation
Introducing disease-associated point mutations (e.g., PFN1 C71G) via CRISPR base editing or HDR recreates patient-specific defects in actin nucleation. These models help dissect molecular mechanisms of ALS and other disorders.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous formin loci allows real-time tracking of protein localization and dynamics without overexpression artifacts. This is valuable for studying nucleation site selection.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of formins increases de novo nucleation, causing excessive filopodia or stress fibers. This approach is used to test sufficiency and gain-of-function effects.
How EDITGENE Supports 'de novo' actin filament nucleation Research
Researchers studying 'de novo' actin filament nucleation-related genes often need to determine whether a candidate gene is causally involved in nucleation, how mutations affect filament assembly, and whether restoring normal function can rescue cellular phenotypes. EDITGENE provides end-to-end CRISPR solutions to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for 'de novo' actin filament nucleation research.
Frequently Asked Questions About 'de novo' actin filament nucleation
What is 'de novo' actin filament nucleation?
'De novo' actin filament nucleation (GO:0070060) is the process where actin monomers assemble into a new filament without a pre-existing filament, producing unbranched filaments, primarily mediated by formins.
What genes are involved in 'de novo' actin filament nucleation?
Key genes include formins (DIAPH1, DIAPH2, FMNL1, INF2), profilins (PFN1, PFN2), and Rho GTPases (RHOA, CDC42).
How is 'de novo' actin filament nucleation different from Arp2/3-mediated nucleation?
De novo nucleation creates unbranched filaments via formins, while Arp2/3 nucleates branched filaments from existing filaments.
What is the role of formins in actin nucleation?
Formins stabilize actin dimers and processively elongate filaments through their FH2 domains, enabling de novo nucleation.
Which diseases are linked to defects in de novo actin nucleation?
Mutations in formins and profilins are linked to cancer, ALS, kidney disease, and deafness.
How can I study 'de novo' actin filament nucleation in the lab?
Common methods include live-cell imaging, pyrene-actin assays, and CRISPR knockout screens.
What is the role of profilin in de novo nucleation?
Profilin binds actin monomers and delivers them to formins, enhancing nucleation and elongation.
Can CRISPR be used to model de novo nucleation diseases?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to study nucleation factor functions and disease mechanisms.
What are the main cellular functions of de novo actin nucleation?
It drives cytokinesis, cell migration, filopodia formation, and nuclear actin dynamics for DNA repair.
How does EDITGENE support research on 'de novo' actin filament nucleation?
EDITGENE offers custom CRISPR knockout, point mutation, knock-in, overexpression, and library screening services tailored to actin nucleation studies.
Conclusion
GO:0070060 'de novo' actin filament nucleation is a fundamental biological process that seeds unbranched actin filaments critical for cell shape, division, and motility. Formins, profilins, and Rho GTPases orchestrate this process, and their dysregulation contributes to cancer, neurodegeneration, and kidney disease. Advances in CRISPR-based models and imaging techniques continue to unravel the molecular details of nucleation, offering new therapeutic opportunities. EDITGENE provides comprehensive CRISPR solutions to accelerate discovery in this dynamic field.
References
- 1. Valencia DA et al.. 2021. Formins.. Curr Biol 31(10):R517-R522 PMID: 34033783
- 2. Dominguez R. 2010. Structural insights into de novo actin polymerization.. Curr Opin Struct Biol 20(2):217-25 PMID: 20096561
- 3. Zweifel ME et al.. 2025. Mechanism of formin-mediated filament nucleation from profilin-actin.. bioRxiv PMID: 40463035
- 4. Xu L et al.. 2024. Cooperative actin filament nucleation by the Arp2/3 complex and formins maintains the homeostatic cortical array in Arabidopsis epidermal cells.. Plant Cell 36(3):764-789 PMID: 38057163
- 5. Caridi CP et al.. 2018. Nuclear F-actin and myosins drive relocalization of heterochromatic breaks.. Nature 559(7712):54-60 PMID: 29925946
- 6. Wiesner S et al.. 2005. Integrin-actin interactions.. Cell Mol Life Sci 62(10):1081-99 PMID: 15761669
- 7. Masedunskas A et al.. 2018. Parallel assembly of actin and tropomyosin, but not myosin II, during de novo actin filament formation in live mice.. J Cell Sci 131(6) PMID: 29487177
